Human Serum Albumin, Recombinant Rice-Derived
drug drugOn this page
Also known as Human serum albuminrecombinant rice-derivedOsrhsa
Summary
Human Serum Albumin, Recombinant Rice-Derived (CHEMBL6068619) is a phase-3 clinical-stage protein.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Protein
- Clinical trials: 2
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL6068619 |
| Name | Human Serum Albumin, Recombinant Rice-Derived |
| Type | Protein |
| Max phase | 3 |
Also known as: Human serum albumin, recombinant rice-derived, Osrhsa, HUMAN SERUM ALBUMIN, RECOMBINANT RICE-DERIVED
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 2.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE3 | 1 |
| PHASE1 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06355479 | PHASE3 | COMPLETED | A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia |
| NCT04384523 | PHASE1 | COMPLETED | A Study of OsrHSA in Adult Healthy Male and Female Volunteers |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.